Daily non-political popular news in brief.

Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients

10-12-2006 · ScienceDaily

By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.

Keywords: mouse, tests, predict, drug, response, relapsing, pancreatic, cancer, patients, test, patient

« Previous | Next »

Similar news on "Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients":

Mouse tests predict drug response in relapsing pancreatic cancer patients
10-11-2006 · EurekAlert!
By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately "test drive" chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
Similar news · Read more »
UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
01-31-2008 · EurekAlert!
Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
Similar news · Read more »
Modeling lung cancer
02-12-2007 · EurekAlert!
In a new report in the February 15 issue of G&D, Dr. Martin McMahon and colleagues present a novel mouse model of non-small cell lung cancer, which will serve as a useful tool to test the efficacy of novel chemotherapeutic drug therapies in the early stages of lung tumorigenesis. Their paper provides evidence to support the use of a relatively new class of drugs, called MEK inhibitors, for lung cancer patients whose tumors contain mutations in the BRaf gene.
Similar news · Read more »
MIT model could predict cells' response to drugs
07-30-2007 · EurekAlert!
MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
Similar news · Read more »
Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy
12-14-2006 · EurekAlert!
Researchers at the University of Texas M. D. Anderson Cancer Center have developed two genomic tests to better predict how breast cancer patients will respond to chemotherapy or hormonal therapy.
Similar news · Read more »
Other highlights in the Nov. 13 JNCI
11-13-2007 · EurekAlert!
Other highlights in the Nov. 13 JNCI include a simple model to predict breast cancer risk, the link between smoking and rectal cancer, research into how a cancer drug causes heart damage, a gene that may inhibit lung cancer, BRCA1's influence on drug response, and the difficulties assigning patients to cancer subtypes.
Similar news · Read more »
Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
09-24-2007 · EurekAlert!
A way of predicting which patients will respond well to treatment with a common chemotherapy drug used in breast cancer was unveiled at the European Cancer Conference (ECCO 14) today (Monday 24 September).
Similar news · Read more »
Liver cancer marker could yield blood test for early detection
09-18-2007 · EurekAlert!
Researchers report on a new blood screening technique that could make it possible to detect early-stage liver cancer and predict how well a patient will do following treatment. They present their data today at the American Association for Cancer Research' Second International Conference on Molecular Diagnostics in Cancer Therapeutic Development, in Atlanta, Ga.
Similar news · Read more »
New HIV test may predict drug resistance
01-07-2007 · EurekAlert!
Researchers at Duke University Medical Center have developed a highly sensitive test for identifying which drug-resistant strains of HIV are harbored in a patient's bloodstream.
Similar news · Read more »
Prior information about normal test results can help reassure patients
01-25-2007 · EurekAlert!
Giving patients prior information about diagnostic tests can help improve patient outcomes and give reassurance, says a new BMJ study. Providing reassurance is a large part of doctors' and other health professionals' roles. Yet many patients remain anxious about their condition even after the results of investigative tests come back 'normal' (i.e. the test does not reveal any particular problems).
Similar news · Read more »